Tempus AI (NASDAQ:TEM) Shares Up 1.2% – Should You Buy?

Tempus AI, Inc. (NASDAQ:TEM) shares traded up 1.2% on Tuesday . The stock traded as high as $65.34 and last traded at $62.29. 8,355,728 shares traded hands during trading, a decline of 20% from the average session volume of 10,424,641 shares. The stock had previously closed at $61.54.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. Bank of America raised their target price on shares of Tempus AI from $52.00 to $54.00 and gave the company a “neutral” rating in a report on Friday, December 13th. Needham & Company LLC restated a “buy” rating and set a $56.00 price objective on shares of Tempus AI in a research report on Tuesday, January 14th. Piper Sandler reissued a “neutral” rating and set a $70.00 price target (up previously from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. Loop Capital lowered their price objective on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a research report on Tuesday, January 14th. Finally, Guggenheim started coverage on shares of Tempus AI in a research note on Monday, December 9th. They issued a “buy” rating and a $74.00 price objective for the company. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $58.55.

Tempus AI Trading Down 6.1 %

The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The stock has a 50 day moving average of $44.32 and a 200-day moving average of $48.73.

Insider Buying and Selling

In other Tempus AI news, major shareholder Bradley A. Keywell sold 395,800 shares of Tempus AI stock in a transaction dated Wednesday, December 11th. The stock was sold at an average price of $42.95, for a total transaction of $16,999,610.00. Following the completion of the transaction, the insider now owns 16,164,449 shares of the company’s stock, valued at $694,263,084.55. The trade was a 2.39 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Eric P. Lefkofsky sold 187,655 shares of the stock in a transaction dated Wednesday, December 18th. The stock was sold at an average price of $37.54, for a total transaction of $7,044,568.70. Following the completion of the sale, the chief executive officer now directly owns 9,557,283 shares in the company, valued at approximately $358,780,403.82. The trade was a 1.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 2,038,072 shares of company stock valued at $89,469,375.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. First Horizon Advisors Inc. purchased a new stake in shares of Tempus AI in the third quarter worth $30,000. FNY Investment Advisers LLC bought a new position in Tempus AI in the 4th quarter worth about $67,000. IFP Advisors Inc purchased a new stake in shares of Tempus AI in the 4th quarter valued at about $76,000. US Bancorp DE bought a new stake in shares of Tempus AI during the 4th quarter valued at about $80,000. Finally, Vestor Capital LLC purchased a new position in shares of Tempus AI during the third quarter worth about $153,000. 24.22% of the stock is owned by institutional investors.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.